364 related articles for article (PubMed ID: 23129054)
41. Regulation of Plasmodium yoelii oocyst development by strain- and stage-specific small-subunit rRNA.
Qi Y; Zhu F; Eastman RT; Fu Y; Zilversmit M; Pattaradilokrat S; Hong L; Liu S; McCutchan TF; Pan W; Xu W; Li J; Huang F; Su XZ
mBio; 2015 Mar; 6(2):e00117. PubMed ID: 25759501
[TBL] [Abstract][Full Text] [Related]
42. High-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission.
Plouffe DM; Wree M; Du AY; Meister S; Li F; Patra K; Lubar A; Okitsu SL; Flannery EL; Kato N; Tanaseichuk O; Comer E; Zhou B; Kuhen K; Zhou Y; Leroy D; Schreiber SL; Scherer CA; Vinetz J; Winzeler EA
Cell Host Microbe; 2016 Jan; 19(1):114-26. PubMed ID: 26749441
[TBL] [Abstract][Full Text] [Related]
43. Functional genomics, new tools in malaria research.
Di Girolamo F; Raggi C; Bultrini E; Lanfrancotti A; Silvestrini F; Sargiacomo M; Birago C; Pizzi E; Alano P; Ponzi M
Ann Ist Super Sanita; 2005; 41(4):469-77. PubMed ID: 16569915
[TBL] [Abstract][Full Text] [Related]
44. Primaquine for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
[TBL] [Abstract][Full Text] [Related]
45. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
Siddiqui FA; Boonhok R; Cabrera M; Mbenda HGN; Wang M; Min H; Liang X; Qin J; Zhu X; Miao J; Cao Y; Cui L
mBio; 2020 Feb; 11(1):. PubMed ID: 32098812
[TBL] [Abstract][Full Text] [Related]
46. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box.
Bowman JD; Merino EF; Brooks CF; Striepen B; Carlier PR; Cassera MB
Antimicrob Agents Chemother; 2014; 58(2):811-9. PubMed ID: 24247137
[TBL] [Abstract][Full Text] [Related]
47. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
48. Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex.
Morais CMG; Brito RMM; Weselucha-Birczyńska A; Pereira VSS; Pereira-Silva JW; Menezes A; Pessoa FAC; Kucharska M; Birczyńska-Zych M; Ríos-Velásquez CM; de Andrade-Neto VF
Front Cell Infect Microbiol; 2022; 12():1047269. PubMed ID: 36530433
[TBL] [Abstract][Full Text] [Related]
49. A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs.
Ruecker A; Mathias DK; Straschil U; Churcher TS; Dinglasan RR; Leroy D; Sinden RE; Delves MJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7292-302. PubMed ID: 25267664
[TBL] [Abstract][Full Text] [Related]
50. A female gametocyte-specific ABC transporter plays a role in lipid metabolism in the malaria parasite.
Tran PN; Brown SH; Mitchell TW; Matuschewski K; McMillan PJ; Kirk K; Dixon MW; Maier AG
Nat Commun; 2014 Sep; 5():4773. PubMed ID: 25198203
[TBL] [Abstract][Full Text] [Related]
51. Using an antimalarial in mosquitoes overcomes Anopheles and Plasmodium resistance to malaria control strategies.
Paton DG; Probst AS; Ma E; Adams KL; Shaw WR; Singh N; Bopp S; Volkman SK; Hien DFS; Paré PSL; Yerbanga RS; Diabaté A; Dabiré RK; Lefèvre T; Wirth DF; Catteruccia F
PLoS Pathog; 2022 Jun; 18(6):e1010609. PubMed ID: 35687594
[TBL] [Abstract][Full Text] [Related]
52. One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Diedrich D; Stenzel K; Hesping E; Antonova-Koch Y; Gebru T; Duffy S; Fisher G; Schöler A; Meister S; Kurz T; Avery VM; Winzeler EA; Held J; Andrews KT; Hansen FK
Eur J Med Chem; 2018 Oct; 158():801-813. PubMed ID: 30245402
[TBL] [Abstract][Full Text] [Related]
53. Tissue schizontocidal effect of trifluoroacetyl primaquine in Plasmodium yoelii infected mice and Plasmodium cynomolgi infected monkeys.
Shao BR; Ye XY
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):81-3. PubMed ID: 1948265
[TBL] [Abstract][Full Text] [Related]
54. Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
Derbyshire ER; Prudêncio M; Mota MM; Clardy J
Proc Natl Acad Sci U S A; 2012 May; 109(22):8511-6. PubMed ID: 22586124
[TBL] [Abstract][Full Text] [Related]
55. Plasmodium falciparum gametocytes: with a view to a kill.
Butterworth AS; Skinner-Adams TS; Gardiner DL; Trenholme KR
Parasitology; 2013 Dec; 140(14):1718-34. PubMed ID: 23953486
[TBL] [Abstract][Full Text] [Related]
56. Malaria research. Parasite genome sequenced, scrutinized.
Pennisi E
Science; 2002 Oct; 298(5591):33-4. PubMed ID: 12364754
[TBL] [Abstract][Full Text] [Related]
57. Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission.
Paton DG; Childs LM; Itoe MA; Holmdahl IE; Buckee CO; Catteruccia F
Nature; 2019 Mar; 567(7747):239-243. PubMed ID: 30814727
[TBL] [Abstract][Full Text] [Related]
58. Plasmodium yoelii vitamin B5 pantothenate transporter candidate is essential for parasite transmission to the mosquito.
Hart RJ; Lawres L; Fritzen E; Ben Mamoun C; Aly AS
Sci Rep; 2014 Jul; 4():5665. PubMed ID: 25012929
[TBL] [Abstract][Full Text] [Related]
59. The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection.
Yanow SK; Purcell LA; Spithill TW
Mol Biochem Parasitol; 2006 Jul; 148(1):52-9. PubMed ID: 16597469
[TBL] [Abstract][Full Text] [Related]
60. Interactions between a fungal entomopathogen and malaria parasites within a mosquito vector.
Heinig RL; Thomas MB
Malar J; 2015 Jan; 14():22. PubMed ID: 25626485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
